Metabolon Raises $15M in Preferred Stock Offering | GenomeWeb

NEW YORK (GenomeWeb News) — Metabolon announced Friday that it has raised $15 million through a private placement of preferred stock.

Investors in the Series E round included Aurora Funds, Harris & Harris Group, Syngenta Ventures, Fletcher Spaght, and Fulcrum Financial Partners, as well as Japanese firm Sumitomo. The round was led by Camden Partners.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: transcriptional and translational study of human cytomegalovirus interactions with host cells, spider web DNA study, and more.

The New York Stem Cell Foundation signs a lease for a new space.

Researchers gear up for an international meeting to discuss the ethics of gene editing.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.